TY - JOUR
T1 - Estimating the odds ratio when exposure has a limit of detection
AU - Cole, Stephen R.
AU - Chu, Haitao
AU - Nie, Lei
AU - Schisterman, Enrique F.
N1 - Funding Information:
American Chemical Council and the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development; NIH grants R03-AI-071763, R01-AA-017594 and P30-AI-50410 (to S.R.C.); Lineberger Cancer Center Core Grant CA16086 from the National Cancer Institute and P30-AI-50410 from the National Institutes of Health (to H.C.); Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health and the American Chemistry Council (to E.F.S.).
PY - 2009/8/10
Y1 - 2009/8/10
N2 - Background: In epidemiologic research, little emphasis has been placed on methods to account for left-hand censoring of 'exposures' due to a limit of detection (LOD). Methods: We calculate the odds of anti-HIV therapy naiveté in 45 HIV-infected men as a function of measured log10 plasma HIV RNA viral load using five approaches including ad hoc methods as well as a maximum likelihood estimate (MLE). We also generated simulations of a binary outcome with 10% incidence and a 1.5-fold increased odds per log increase in a log-normally distributed exposure with 25, 50 and 75% of exposure data below LOD. Simulated data were analysed using the same five methods, as well as the full data. Results: In the example, the estimated odds ratio (OR) varied by 1.22-fold across methods, from 1.45 to 1.77 per log10 copies of viral load and the standard error for the log OR varied by 1.52-fold across methods, from 0.31 to 0.47. In the simulations, use of full data or the MLE was unbiased with appropriate confidence interval (CI) coverage. However, as the proportion of exposure below LOD increased, substituting LOD, LOD/√2 or LOD/2 was increasingly biased with increasingly inappropriate CI coverage. Finally, exclusion of values below LOD was unbiased but imprecise. Conclusions: In this example and the settings explored by simulation, and among methods readily available to investigators (i.e. sans full data), the MLE provided an unbiased and appropriately precise estimate of the exposure-outcome OR. Published by Oxford University Press on behalf of the International Epidemiological Association.
AB - Background: In epidemiologic research, little emphasis has been placed on methods to account for left-hand censoring of 'exposures' due to a limit of detection (LOD). Methods: We calculate the odds of anti-HIV therapy naiveté in 45 HIV-infected men as a function of measured log10 plasma HIV RNA viral load using five approaches including ad hoc methods as well as a maximum likelihood estimate (MLE). We also generated simulations of a binary outcome with 10% incidence and a 1.5-fold increased odds per log increase in a log-normally distributed exposure with 25, 50 and 75% of exposure data below LOD. Simulated data were analysed using the same five methods, as well as the full data. Results: In the example, the estimated odds ratio (OR) varied by 1.22-fold across methods, from 1.45 to 1.77 per log10 copies of viral load and the standard error for the log OR varied by 1.52-fold across methods, from 0.31 to 0.47. In the simulations, use of full data or the MLE was unbiased with appropriate confidence interval (CI) coverage. However, as the proportion of exposure below LOD increased, substituting LOD, LOD/√2 or LOD/2 was increasingly biased with increasingly inappropriate CI coverage. Finally, exclusion of values below LOD was unbiased but imprecise. Conclusions: In this example and the settings explored by simulation, and among methods readily available to investigators (i.e. sans full data), the MLE provided an unbiased and appropriately precise estimate of the exposure-outcome OR. Published by Oxford University Press on behalf of the International Epidemiological Association.
KW - Biomarkers
KW - Epidemiologic methods
KW - Limit of detection
KW - Statistical method
UR - http://www.scopus.com/inward/record.url?scp=75349102030&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=75349102030&partnerID=8YFLogxK
U2 - 10.1093/ije/dyp269
DO - 10.1093/ije/dyp269
M3 - Article
C2 - 19667054
AN - SCOPUS:75349102030
SN - 0300-5771
VL - 38
SP - 1674
EP - 1680
JO - International journal of epidemiology
JF - International journal of epidemiology
IS - 6
M1 - dyp269
ER -